Comparative statistics by cancer registry
Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
(Bhopal, India, 1991-1995 cases followed-up until 2000)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | Total | Absolute survival % | Relative survival % | ASRS% at 5-years | ||||||
| 1-year | 3-year | 5-year | 1-year | 3-year | 5-year | all ages | 0-74 years | ||||
| C01-02 | Tongue | 127 | 52.8 | 20.5 | 9.4 | 54.8 | 22.6 | 10.8 | 11.7 | 13.1 | |
| C03-06 | Oral cavity | 172 | 80.2 | 45.9 | 29.1 | 83.0 | 50.4 | 33.6 | 33.9 | 37.5 | |
| C12-13 | Hypopharynx | 118 | 50.8 | 16.9 | 1.7 | 52.7 | 18.6 | 2.0 | 1.7 | 2.0 | |
| C15 | Oesophagus | 163 | 36.2 | 12.9 | 3.1 | 37.6 | 14.1 | 3.5 | 2.7 | 3.6 | |
| C16 | Stomach | 75 | 38.7 | 5.3 | 2.7 | 39.8 | 5.8 | 2.9 | 2.8 | 3.8 | |
| C18 | Colon | 48 | 52.1 | 25.0 | 6.3 | 53.9 | 27.1 | 7.0 | 3.2 | 5.2 | |
| C19-20 | Rectum | 39 | 56.4 | 25.6 | 7.7 | 58.0 | 27.2 | 8.5 | 4.0 | 6.5 | |
| C32 | Larynx | 60 | 61.7 | 23.3 | 6.7 | 63.6 | 25.4 | 7.8 | 12.5 | 15.7 | |
| C33-34 | Lung | 216 | 33.3 | 6.9 | 0.9 | 34.7 | 7.7 | 1.1 | 0.8 | 1.0 | |
| C50 | Breast | 261 | 83.1 | 62.1 | 30.7 | 84.5 | 64.8 | 32.8 | 25.3 | 30.6 | |
| C53 | Cervix | 332 | 88.9 | 66.0 | 33.1 | 90.3 | 68.8 | 35.4 | 30.8 | 34.5 | |
| C56 | Ovary | 69 | 63.8 | 47.8 | 18.8 | 64.8 | 49.7 | 20.1 | 15.8 | 18.9 | |
| C67 | Urinary bladder | 46 | 54.3 | 17.4 | 6.5 | 57.1 | 19.6 | 7.8 | 6.0 | 9.7 | |
| C82-85+C96 | Non-Hodgkin lymphoma | 30 | 33.3 | 16.7 | 10.0 | 33.9 | 17.3 | 10.5 | 8.8 | 9.9 | |
| C91 | Lymphoid leukaemia | 32 | 46.9 | 31.3 | 12.5 | 47.5 | 32.1 | 13.1 | 10.4 | 12.6 | |
| C92-94 | Myeloid leukaemia | 75 | 61.3 | 33.3 | 16.0 | 62.0 | 34.3 | 16.7 | 12.3 | 14.2 | |
Graphs:
 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table2b: | Number and proportion of cases by vital status and median follow-up (in months) by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Bhopal, India, 1991-1995 cases followed-up until 2000) |
| - Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Bhopal, India, 1991-1995) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |